The study group comprised 13 patients (mean age 68 years) with clinically fixed and biopsy proven moderately differentiated rectal adenocarcinoma (8 high rectal, 5 low-mid rectal) who received synchronous courses ofpreoperative combination chemotherapy and pelvic radiotherapy (radiotherapy alone in 3 cases) over a period of 8-20 weeks prior to surgical resection. All cases showed varying degrees of mural and mesorectal fibrosis. Three cases did not differ otherwise from usual rectal adenocarcinoma while 4 had a 20-30 % diminution in expected tumour area. In 6 cases tumour could not be definitely identified grossly -1 showed a 50% reduction in tumour bulk while 5 had only residual microscopic foci from 0.6 -4 mm in maximum dimensions. Only 3 cases had involvement of the mesorectal circumferential radial margin. Four involved lymph nodes in 2 cases were partially hyalinised and calcified. Preoperative combination adjuvant therapy can produce marked regressive morphological changes in rectal adenocarcinoma. The implications of this are discussed.
INTRODUCTION
Early work by Papillon' illustrated the preservative and curative potential of locally applied irradiation in the treatment of limited cancers of the rectum and anus. Stevens et a12 reported that preoperative radiotherapy decreased local pelvic recurrence and increased 5 year survival in 97 patients with recto-sigmoid adenocarcinoma. Of these the tumour field was sterilised in nine cases and there were only residual microscopic foci in another three. Others have noted preoperative radiotherapy to give decreased local recurrence rates3 7 (although this is not universally accepted8), increased 5 year survival,'3' 7 improved resectability5 6 9 and facilitation of local excision in medically unfit patients.'0 Regression of disease in involved lymph nodes producing "down staging" has also been reported. 3 4',7 It appears that radiotherapy is more effective when combined with chemotherapy6 11 although there is some debate as to whether preoperative or post operative treatment is better.6 These potential benefits are presumably as a result ofregression in the tumour tissue induced by the adjuvant therapy. Morphological aspects of this are described in this paper.
METHODS
The 13 patients (9 male) aged between 48 and 84 years (mean 68) had biopsy proven rectal adenocarcinoma (8 high rectum, 5 low-mid rectum) and clinically fixed, tethered lesions (2 had evidence of liver metastases). In all cases potential for curative surgical resection was considered clinically to be either borderline or not possible. After diagnosis they received pelvic radiotherapy comprising 40 Gray in 20 fractions over a period of 4 
